Florida Cancer Specialists & Research Institute Contributes to Phase 1 Study Demonstrating Antitumor Activity with First-in-Class KRAS-Targeted Therapy for Treatment of Lung ...

Setidegrasib results published in New England Journal of Medicine FORT MYERS, Fla., April 2, 2026 /PRNewswire/ -- Results of a Phase 1 clinical study conducted with participation from Florida Cancer ...
Science Daily

Scientists discover why this deadly lung cancer keeps coming back

Scientists have discovered that losing a key protein in small cell lung cancer triggers inflammation that actually helps ...

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

In some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a ...
WTVD

Duke researchers discover new origin of small cell lung cancer in study

DURHAM, N.C. (WTVD) -- Small cell lung cancer is one of the most aggressive and deadly forms of lung cancer commonly associated with smoking. Now, researchers at Duke Health have uncovered a ...
CURE

ELCC 2026 Highlights Real Patient Impact in Lung Cancer Care

New ELCC 2026 data show longer survival, better brain metastases control and more personalized treatment options for patients ...
The American Journal of Managed Care

Search Continues for New Biomarkers in NSCLC

Recent research is helping to expand the potential biomarker landscape in non–small cell lung cancer (NSCLC) and may soon ...
News Medical

Study finds a new protein target against KRAS-driven non-small cell lung cancer

Lung cancer is the second-most common cancer and the leading cause of cancer death in the United States. Over 80% of lung cancers are non-small cell lung cancers, in which tumor cells are larger and ...